Showing results (111-120 of 136) with videos related to
Sort By:
Pageof 14
Nature Medicine|February 24, 2023
Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trialIngo K Mellinghoff, Min Lu, Patrick Y Wen, et al.Neuro-Oncology|August 5, 2011
Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?Jennifer L Clarke, Michele M Ennis, W K Alfred Yung, et al.Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Functional germline variants in DNA damage repair pathways are associated with altered survival in adults with glioma treated with temozolomideGeno Guerra, George Wendt, Lucie McCoy, et al.Neuro-Oncology|January 2, 2025
Functional germline variants in DNA damage repair pathways are associated with altered survival in adults with glioma treated with temozolomideGeno Guerra, George Wendt, Lucie McCoy, et al.Neuro-Oncology|October 28, 2017
Genomic analysis of the origins and evolution of multicentric diffuse lower-grade gliomasJosie Hayes, Yao Yu, Llewellyn E Jalbert, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2021
Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I TrialIngo K Mellinghoff, Marta Penas-Prado, Katherine B Peters, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2026
A genomically-tailored multi-agent precision medicine clinical trial for adults with recurrent glioblastomaJiaying Chen, Nancy Ann Oberheim Bush, Jennifer A Grabowsky, et al.Neuro-Oncology Advances|December 23, 2020
Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adultsJessica D Schulte, Robin A Buerki, Sarah Lapointe, et al.Journal of Neurosurgery. Spine|August 20, 2021
A multicenter analysis of the prognostic value of histone H3 K27M mutation in adult high-grade spinal gliomaOluwaseun O Akinduro, Diogo P Garcia, Dominique M O Higgins, et al.Neuro-Oncology|April 6, 2021
Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomasYao Yu, Javier Villanueva-Meyer, Matthew R Grimmer, et al.Pageof 14